Mark James Daniel's most recent trade in Atossa Therapeutics Inc was a trade of 63,000 Common Stock done . Disclosure was reported to the exchange on March 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atossa Therapeutics Inc | Mark James Daniel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2026 | 63,000 | 63,000 (0%) | 0% | 0 | Common Stock | |
| Atossa Therapeutics Inc | Mark James Daniel | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2025 | 578,000 | 578,000 | - | - | Stock Option (right to buy) |